Clinical trial
Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
NCT00034853
Study timeline
Study start (unknown)2000-12-01Date precision: month
Registry last updated2013-11-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Arthritis, Juvenile Rheumatoidunresolved
Interventions
meloxicam oral suspensionDRUG · verified · RxNorm: meloxicam Oral Suspension
naproxen oral suspensionDRUG · verified · RxNorm: naproxen Oral Suspension
Sponsors & collaborators
Boehringer Ingelheimlead sponsor
Mapped research locations
St LouisMissouri, United States2New YorkNew York, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1DallasTexas, United States1MiamiFlorida, United States1SeattleWashington, United States1San DiegoCalifornia, United States1DenverColorado, United States1Oklahoma CityOklahoma, United States1OmahaNebraska, United States1Salt Lake CityUtah, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00034853 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.